Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)

v3.22.1
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended
Nov. 16, 2021
USD ($)
$ / shares
shares
Jan. 31, 2022
USD ($)
item
Mar. 31, 2021
Mar. 31, 2022
USD ($)
item
$ / shares
Jan. 12, 2022
USD ($)
Dec. 31, 2021
USD ($)
$ / shares
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Number of branded drugs in product portfolio | item   9   9    
Number of authorized generic prescription drugs | item       3    
Cash and cash equivalents       $ 41,331   $ 49,081
Common Stock, Par or Stated Value Per Share | $ / shares       $ 0.0001   $ 0.0001
Fortress Note            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Number of shares issued for conversion of related part debt | shares 1,610,467          
IPO            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Proceeds of initial public offering $ 30,600          
Common Stock, Par or Stated Value Per Share | $ / shares $ 0.0001          
IPO | Fortress Note            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Price per share | $ / shares $ 10.00          
Cumulative Convertible Class A Preferred Stock            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Preferred stock dividend rate     8.00% 8.00%    
Number of shared issued for conversion of preferred stock | shares 2,231,346          
Price per share | $ / shares       $ 25.00    
East West Bank            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Maximum borrowing capacity       $ 0 $ 30,000  
Term Loan            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Maximum borrowing capacity         20,000  
Current borrowing capacity   $ 15,000     15,000  
Revolving Credit Facility | East West Bank            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Maximum borrowing capacity         $ 10,000  
Additional borrowing capacity   $ 5,000